1. Exploring regulatory network of metabolism through liver research

   • Motoharu Awazawa

   Review Article 26 August 2021 Pages: 343 - 348

   

2. Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes

   • Jun Shirakawa

   Review Article 17 August 2021 Pages: 349 - 355

   

3. Association of glycemic control and anthropometric measurement among type 2 diabetes mellitus: a cross-sectional study

   • Mitku Mammo Taderegew
   • Mamo Solomon Emeria
   • Betregiorgis Zegeye

   Original Article 25 January 2021 Pages: 356 - 363

   

4. Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial

   • Fumio Sawano
   • Nozomu Kamei
   • Tadahiro Kitamura

   Original Article 11 February 2021 Pages: 364 - 378

   

5. Determinants of type 2 diabetes remission after bariatric surgery in obese Japanese patients: a retrospective cohort study

   • Masahiro Ohira
   • Yasuhiro Watanabe
   • Ichiro Tatsuno

   Original Article 28 January 2021 Pages: 379 - 388

6. Sodium-glucose cotransporter 2 inhibitor canagliflozin attenuates lung cancer cell proliferation in vitro

   • Leona Yamamoto
   • Shinichi Yamashita
   • Akinori Iwasaki

   Original Article 16 February 2021 Pages: 389 - 398

   

7. Evaluation of multiple drug use in patients with type 2 diabetes mellitus

   • Habibe İnci

   Original Article 07 February 2021 Pages: 399 - 404

   

8. Associations of serum transthyretin with triglyceride in non-obese elderly Japanese women independently of insulin resistance, HDL cholesterol, and adiponectin

   • Satomi Minato-Inokawa
   • Ayaka Tsuboi
   • Keisuke Fukuo

   Original Article 13 February 2021 Pages: 405 - 411

   

9. Prevalence of obesity in prepubertal and pubertal with Turkish population type 1 diabetes

   • Volkan Özkaya
   • Erdal Eren
   • Yasemin Denkboy Öngen

   Original Article 18 February 2021 Pages: 412 - 419

   

10. Increased nutrition-related risk as an independent predictor of the incidence of hypoglycemia in the hospitalized older individuals with type 2 diabetes: a single-center cohort study

    • Yoshinobu Kimura
    • Naoya Kimura
    • Manabu Akazawa

    Original Article 17 February 2021 Pages: 420 - 429

    

11. Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)

    • Hiroshi Maegawa
    • Kazuyuki Tobe
    • Satoshi Uno

    Original Article 24 March 2021 Pages: 430 - 444

    

12. Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis

    • Vasileios P. Papadopoulos
    • Marios-Vasileios Koutroulos
    • Dimitrios K. Filippou

    Original Article 23 March 2021 Pages: 445 - 459

    

13. Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults’ Glycemia in T1DM subanalysis

    • Norio Abiru
    • Akira Shimada
    • Hiroshi Ikegami

    Original Article 25 April 2021 Pages: 460 - 473

    

14. Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report

    • Atsushi Satomura
    • Yoichi Oikawa
    • Akira Shimada

    Case Report 01 March 2021 Pages: 474 - 479

    

15. Unilateral adrenalectomy partially improved hyperglycemia in a patient with primary bilateral macronodular adrenal hyperplasia

    • Mitsuru Nishiyama
    • Takashi Karashima
    • Shimpei Fujimoto

    Case Report 10 April 2021 Pages: 480 - 484